XSPRAY Xspray Pharma AB (publ)

1.004USD10.18 SEK · STO-2.86%Mkt Cap: 49.95M USDP/E: —

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the…